HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 34 filers reported holding HARPOON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -38.7% | 9,287 | -6.6% | 0.00% | – |
| Q4 2021 | $75,000 | -7.4% | 9,940 | -2.9% | 0.00% | – |
| Q3 2021 | $81,000 | -44.1% | 10,238 | -2.3% | 0.00% | – |
| Q2 2021 | $145,000 | -12.1% | 10,481 | +32.7% | 0.00% | -100.0% |
| Q1 2021 | $165,000 | +58.7% | 7,896 | +26.5% | 0.00% | – |
| Q4 2020 | $104,000 | -2.8% | 6,241 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $107,000 | 0.0% | 6,323 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | +114.0% | 6,467 | +49.0% | 0.00% | – |
| Q1 2020 | $50,000 | -26.5% | 4,341 | -5.5% | 0.00% | – |
| Q4 2019 | $68,000 | +7.9% | 4,593 | +0.3% | 0.00% | – |
| Q3 2019 | $63,000 | +28.6% | 4,580 | +21.5% | 0.00% | – |
| Q2 2019 | $49,000 | +226.7% | 3,771 | +130.5% | 0.00% | – |
| Q1 2019 | $15,000 | – | 1,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $75,105,000 | 22.35% |
| MPM BioImpact LLC | 3,898,422 | $64,714,000 | 17.21% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $48,495,000 | 13.92% |
| Avidity Partners Management LP | 1,206,351 | $20,025,000 | 1.28% |
| Consonance Capital Management LP | 844,162 | $14,013,000 | 0.84% |
| Orbimed Advisors | 1,835,704 | $30,473,000 | 0.43% |
| Artal Group S.A. | 900,000 | $14,940,000 | 0.42% |
| Cormorant Asset Management, LP | 645,257 | $10,711,000 | 0.41% |
| DAFNA Capital Management LLC | 85,119 | $1,413,000 | 0.41% |
| Soleus Capital Management, L.P. | 30,886 | $512,000 | 0.29% |